ABSTRACT:Flurbiprofen is a nonsteroidal anti-inflammatory drug used as a racemic mixture. Although glucuronidation is one of its elimination pathways, the role of UDP-glucuronosyltransferase (UGT) in this process remains to be investigated. Thus, the kinetics of the stereoselective glucuronidation of racemic (R,S)-flurbiprofen by recombinant UGT isozymes and human liver microsomes (HLMs) were investigated, and the major human UGT isozymes involved were identified. UGT1A1, 1A3, 1A9, 2B4, and 2B7 showed glucuronidation activity for both (R)-and (S)-glucuronide, with UGT2B7 possessing the highest activity. UGT2B7 formed the (R)-glucuronide at a rate 2.8-fold higher than that for (S)-glucuronide, whereas the other UGTs had similar formation rates. The glucuronidation of racemic flurbiprofen by HLMs also resulted in the formation of (R)-glucuronide as the dominant form, which occurred to a degree similar to that by recombinant UGT2B7 (2.1 versus 2.8). The formation of (R)-glucuronide correlated significantly with morphine 3-OH glucuronidation (r ؍ 0.96, p < 0.0001), morphine 6-OH glucuronidation (r ؍ 0.91, p < 0.0001), and 3-azido-3-deoxythymidine glucuronidation (r ؍ 0.85, p < 0.0001), a reaction catalyzed mainly by UGT2B7, in individual HLMs. In addition, the formation of both glucuronides correlated significantly (r ؍ 0.99, p < 0.0001). Mefenamic acid inhibited the formation of both (R)-and (S)-glucuronide in HLMs with similar IC 50 values (2.0 and 1.7 M, respectively), which are close to those in recombinant UGT2B7. In conclusion, these findings suggest that the formation of (R)-and (S)-glucuronide from racemic flurbiprofen is catalyzed by the same UGT isozyme, namely UGT2B7. Fig. 1) is commonly used as an analgesic nonsteroidal anti-inflammatory drug. Although the anti-inflammatory activity is almost entirely attributable to (S)-flurbiprofen (Kulmacz and Lands, 1985), it has been suggested that both (R)-and (S)-flurbiprofen may possess antinociceptive activity (Brune et al., 1991;Geisslinger and Schaible, 1996). In addition, both enantiomers have been shown to exhibit antiproliferative effects (McCracken et al., 1996). Flurbiprofen exists as a chiral compound with a stereoselective disposition in humans (Geisslinger et al., 1994) and is metabolized via several drug metabolizing pathways, including cytochromes P450 and UDP-glucuronosyltransferases (UGTs). Approximately 60 to 70% of the administered dose is eliminated as acyl glucuronides (Davies, 1995). After oral administration of racemic flurbiprofen (100 mg/kg), 8.4 and 7.3% of the dose was excreted into the urine as the acyl glucuronide of (R)-and (S)-flurbiprofen, respectively (Patel et al., 2003). However, the flurbiprofen glucuronidation fraction is difficult to determine and may be higher because of the instability of acyl glucuronides in vivo. The data from these reports suggest that the formation of glucuronide constitutes some portion of the metabolic pathway of flurbiprofen. The other major oxidative metabolite (4Ј-hydroxyflurbiprofen) and min...